Over-the-Counter Monograph Drug User Fee Amendments

# Bill Summary: Over-the-Counter Monograph Drug User Fee Amendments (HR 4273) ## What the Bill Would Do This bill would establish or modify user fees that companies must pay to the FDA when submitting certain over-the-counter (OTC) medications for review and approval. OTC drugs are medicines you can buy without a prescription, like pain relievers, cold medicines, and antacids. The fees would help fund the FDA's review process for these medications, which currently falls under the "monograph" system—a streamlined pathway for drugs with established, safe ingredients. ## Who It Affects and Key Provisions The bill primarily affects pharmaceutical companies that manufacture and sell OTC medications, as they would bear the cost of the new fees. Consumers could potentially see indirect effects if companies pass costs along through higher prices.

The legislation involves Congressional oversight of how these fees are set and used, and relates to drug safety and FDA regulatory processes. The specific fee amounts and structures aren't detailed in this summary, as the bill remains in committee. ## Current Status As of now, HR 4273 is in committee and has not yet been voted on by the full House. This is an early stage in the legislative process, meaning it's still under review and discussion before any floor vote would occur.